ALBANY MOLECULAR RESEARCH $11.35

up +0.27


20/5/2013 10:20 AM  |  NASDAQ : AMRI  |  Industries : Professional, Scientific, and Technical Services / Scientific Research and Development Services
Last Trade: 11.35
Trade Time: May 20 10:04 AM Eastern Daylight Time
Change: 0.27 (2.44 %)
Prev Close: 11.08
Open: 11.03
Bid: 11.34
Ask: 11.37
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing AMRI also viewed: , , , ,

Competitors

Ticker Name Volume % Change
INKN SHRINK NANOTECHNOLOGIES 1.0K +0.19%
OXBT OXYGEN BIOTHERAPEUTICS; INC. C 100.0 +0.05%
INCY INCYTE 99.3K +0.03%
OOIL ORIGINOIL 21.2K +0.02%
EXAS EXACT SCIENCES 89.1K +0.01%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/10/2013 Hagen Steven R Sr VP Pharmaceutical Dev & Mfg -1,200 $10.40 -3.55%
3/19/2013 Sargent Bruce J Sr VP, Drug Discovery -258 $9.91 -0.45%
3/19/2013 Hagen Steven R Sr VP Pharmaceutical Dev & Mfg -180 $9.91 -0.53%
3/18/2013 Sargent Bruce J Sr VP, Drug Discovery -256 $9.98 -0.44%
3/18/2013 Hagen Steven R Sr VP Pharmaceutical Dev & Mfg -249 $9.98 -0.73%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (AMRI), click here.

AMRI Stock Analysis

  1. The “Healthy” Play In Contract Research Organizations

    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1. View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  2. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
  3. Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center